White Paper

Facts about Naloxone: The Opioid Overdose Rescue Drug

Many states and the US government have declared the opioid epidemic as a public health emergency. Action is elicited from stakeholders at all levels of the health care spectrum.

White Paper Summary

Naloxone is an opioid antagonist that blocks the effects of opioids and reverses an overdose. This medication is an essential tool that can be used in the event of an opioid overdose and has its role in the current opioid epidemic. While it is crucial to implement strategies toward reducing inappropriate use that leads to abuse and addiction in the first place, rescuing patients from overdoses will dramatically reduce mortality associated with opioid misuse.

For this reason, all 51 US jurisdictions have enacted naloxone access laws that remove varying levels of restrictions for naloxone. The next step however, appears to be the enactment of naloxone co-prescribing laws.

To learn more about myMatrixx, please visit their website.

myMatrixx is a full-service pharmacy and ancillary medical benefits management company focusing on the “Customer Experience.”

More from Risk & Insurance

More from Risk & Insurance

Risk Matrix: Presented by Liberty Mutual Insurance

11 Crucial Trends That Are Impacting the Construction Industry Today

Increased hurricanes, opioids, women workers and more are just some of the latest trends driving construction risk.
By: | November 1, 2019

The R&I Editorial Team can be reached at [email protected]